We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current COLL market cap is 1.16B. The company's latest EPS is USD 1.5067 and P/E is 24.17.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 127.01M | 129.62M | 144.77M | 135.55M | 136.71M |
| Operating Income | 20.47M | 11.76M | 24.63M | 35.63M | 45.01M |
| Net Income | 457k | -7.2M | -17.43M | 13.01M | 20.63M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 296.7M | 310.02M | 276.87M | 463.93M | 566.77M |
| Operating Income | -23.75M | 56.23M | 17.63M | 33.32M | 166.96M |
| Net Income | -22.72M | 26.75M | 71.52M | -25M | 48.16M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.2B | 1.17B | 1.21B | 1.21B | 1.18B |
| Total Liabilities | 1B | 979.29M | 1.03B | 1.01B | 998.71M |
| Total Equity | 197.19M | 194.84M | 179.73M | 200.81M | 178.87M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 306.3M | 643.84M | 692.08M | 1.17B | 1.14B |
| Total Liabilities | 218.87M | 457.81M | 489.15M | 979.29M | 947.88M |
| Total Equity | 87.43M | 186.03M | 202.93M | 194.84M | 195.43M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 57.91M | 124.23M | 27.67M | 127.39M | 201.41M |
| Investing | -572.75M | -573.69M | -176k | -41.89M | -45.72M |
| Financing | 462.55M | 436.72M | 68.3M | 23.06M | -72.35M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 27.78M | 93.94M | 103.56M | 124.23M | 274.75M |
| Investing | -6.44M | -373.77M | -1.94M | -573.69M | -70.81M |
| Financing | 2.04M | 286.47M | -89.3M | 436.72M | -140.18M |
| Market Cap | 1.16B |
| Price to Earnings Ratio | 24.17 |
| Price to Sales Ratio | 2.05 |
| Price to Cash Ratio | 4.87 |
| Price to Book Ratio | 5.96 |
| Dividend Yield | - |
| Shares Outstanding | 31.96M |
| Average Volume (1 week) | 406.89k |
| Average Volume (1 Month) | 340.07k |
| 52 Week Change | 58.49% |
| 52 Week High | 40.95 |
| 52 Week Low | 20.83 |
| Spread (Intraday) | 0.28 (0.76%) |
| Company Name | Collegium Pharmaceutical Inc |
| Address |
100 shockoe slip richmond, virginia 23219 4100 |
| Website | https://www.collegiumpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
